234 related articles for article (PubMed ID: 10956411)
1. Alteration of the cytoplasmic/nuclear expression pattern of galectin-3 correlates with prostate carcinoma progression.
van den Brûle FA; Waltregny D; Liu FT; Castronovo V
Int J Cancer; 2000 Jul; 89(4):361-7. PubMed ID: 10956411
[TBL] [Abstract][Full Text] [Related]
2. Galectin-1 and galectin-3 expression in human prostate tissue and prostate cancer.
Ellerhorst J; Troncoso P; Xu XC; Lee J; Lotan R
Urol Res; 1999 Oct; 27(5):362-7. PubMed ID: 10550525
[TBL] [Abstract][Full Text] [Related]
3. p63 cytoplasmic aberrance is associated with high prostate cancer stem cell expression.
Ferronika P; Triningsih FX; Ghozali A; Moeljono A; Rahmayanti S; Shadrina AN; Naim AE; Wudexi I; Arnurisa AM; Nanwani ST; Harijadi A
Asian Pac J Cancer Prev; 2012; 13(5):1943-8. PubMed ID: 22901151
[TBL] [Abstract][Full Text] [Related]
4. Expression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma.
Honjo Y; Inohara H; Akahani S; Yoshii T; Takenaka Y; Yoshida J; Hattori K; Tomiyama Y; Raz A; Kubo T
Clin Cancer Res; 2000 Dec; 6(12):4635-40. PubMed ID: 11156213
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of galectin-1 in carcinoma-associated stroma predicts poor outcome in prostate carcinoma patients.
van den Brûle FA; Waltregny D; Castronovo V
J Pathol; 2001 Jan; 193(1):80-7. PubMed ID: 11169519
[TBL] [Abstract][Full Text] [Related]
6. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.
Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Bostwick DG
J Urol; 1999 Apr; 161(4):1229-32. PubMed ID: 10081875
[TBL] [Abstract][Full Text] [Related]
7. Decreased galectin-3 expression in prostate cancer.
Pacis RA; Pilat MJ; Pienta KJ; Wojno K; Raz A; Hogan V; Cooper CR
Prostate; 2000 Jul; 44(2):118-23. PubMed ID: 10881021
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression.
Wu GJ; Wu MW; Wang SW; Liu Z; Qu P; Peng Q; Yang H; Varma VA; Sun QC; Petros JA; Lim SD; Amin MB
Gene; 2001 Nov; 279(1):17-31. PubMed ID: 11722842
[TBL] [Abstract][Full Text] [Related]
9. Dual activities of galectin-3 in human prostate cancer: tumor suppression of nuclear galectin-3 vs tumor promotion of cytoplasmic galectin-3.
Califice S; Castronovo V; Bracke M; van den Brûle F
Oncogene; 2004 Sep; 23(45):7527-36. PubMed ID: 15326483
[TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostate carcinoma and androgen-independent status.
Hong H; Kao C; Jeng MH; Eble JN; Koch MO; Gardner TA; Zhang S; Li L; Pan CX; Hu Z; MacLennan GT; Cheng L
Cancer; 2004 Jul; 101(1):83-9. PubMed ID: 15221992
[TBL] [Abstract][Full Text] [Related]
11. Seminal plasma proteins in prostatic carcinoma: increased nuclear semenogelin I expression is a predictor of biochemical recurrence after radical prostatectomy.
Izumi K; Li Y; Zheng Y; Gordetsky J; Yao JL; Miyamoto H
Hum Pathol; 2012 Nov; 43(11):1991-2000. PubMed ID: 22617231
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of NSAID-activated gene product in prostate cancer.
Iczkowski KA; Pantazis CG
Int J Surg Pathol; 2003 Jul; 11(3):159-66. PubMed ID: 12894347
[TBL] [Abstract][Full Text] [Related]
13. Increase of AKT/PKB expression correlates with gleason pattern in human prostate cancer.
Liao Y; Grobholz R; Abel U; Trojan L; Michel MS; Angel P; Mayer D
Int J Cancer; 2003 Nov; 107(4):676-80. PubMed ID: 14520710
[TBL] [Abstract][Full Text] [Related]
14. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases.
Bostwick DG; Pacelli A; Blute M; Roche P; Murphy GP
Cancer; 1998 Jun; 82(11):2256-61. PubMed ID: 9610707
[TBL] [Abstract][Full Text] [Related]
15. STEAP1 is overexpressed in prostate cancer and prostatic intraepithelial neoplasia lesions, and it is positively associated with Gleason score.
Gomes IM; Arinto P; Lopes C; Santos CR; Maia CJ
Urol Oncol; 2014 Jan; 32(1):53.e23-9. PubMed ID: 24239460
[TBL] [Abstract][Full Text] [Related]
16. Activation of nuclear factor-kappaB in human prostate carcinogenesis and association to biochemical relapse.
Domingo-Domenech J; Mellado B; Ferrer B; Truan D; Codony-Servat J; Sauleda S; Alcover J; Campo E; Gascon P; Rovira A; Ross JS; Fernández PL; Albanell J
Br J Cancer; 2005 Nov; 93(11):1285-94. PubMed ID: 16278667
[TBL] [Abstract][Full Text] [Related]
17. Golgi Phosphoprotein-3 and Y-Box-Binding Protein-1 Are Novel Markers Correlating With Poor Prognosis in Prostate Cancer.
Abd El-Maqsoud NM; Osman NA; Abd El-Hamid AM; Fath El-Bab TK; Galal EM
Clin Genitourin Cancer; 2016 Apr; 14(2):e143-52. PubMed ID: 26794392
[TBL] [Abstract][Full Text] [Related]
18. Expression of prostate specific membrane antigen (PSMA) in prostatic adenocarcinoma and prostatic intraepithelial neoplasia.
Marchal C; Redondo M; Padilla M; Caballero J; Rodrigo I; García J; Quian J; Boswick DG
Histol Histopathol; 2004 Jul; 19(3):715-8. PubMed ID: 15168332
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of cytokeratin mRNA and protein in normal prostate, prostatic intraepithelial neoplasia, and invasive carcinoma.
Yang Y; Hao J; Liu X; Dalkin B; Nagle RB
Am J Pathol; 1997 Feb; 150(2):693-704. PubMed ID: 9033282
[TBL] [Abstract][Full Text] [Related]
20. Decreased retinoid X receptor-alpha protein expression in basal cells occurs in the early stage of human prostate cancer development.
Mao GE; Reuter VE; Cordon-Cardo C; Dalbagni G; Scher HI; DeKernion JB; Zhang ZF; Rao J
Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):383-90. PubMed ID: 15006913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
